Funding for this research was provided by:
British Heart Foundation (FS/13/59/30649)
Cancer Research UK (C1417/A22962)
Article History
First Online: 30 July 2018
Compliance with Ethical Standards
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Research Ethics Committee at the University College London (6212/002).
: Informed consent was obtained from all individual participants included in the study.
: AH is working as a Consultant and Project Lead at Health Promotion Foundation in Poland, received funds from an unrestricted educational grant from Pfizer as part of Global Bridges Programme for capacity building, and led work on development of NRT2Quit app used as a prompt in the study. LS has received honoraria for talks an unrestricted research grant and travel expenses to attend meetings and workshops from Pfizer and Johnson&Johnson and has acted as paid reviewer for grant awarding bodies and as a paid consultant for health care companies. RW undertakes research and consultancy and receives fees for speaking from companies that develop and manufacture smoking cessation medications (Pfizer, J&J, McNeil, GSK, Nabi, Novartis, and Sanofi-Aventis) and has a share of a patent for a novel nicotine delivery device. IT has no conflicts of interest. The research team is part of the UCL Tobacco and Alcohol Research Group.